The production of the Favipiravir antiviral drug that will be used in COVID-19 vaccines will commence in December, the press service of the Russian pharmaceutical company Promomed told Sputnik.
UN Secretary-General Antonio Guterres on Monday called for vaccine equity and continued vigilance against the coronavirus as global COVID-19 deaths exceeded 5 million.